CD44 expressed by myeloid cells promotes glioma invasion
Glioblastoma multiforme (GBM) is one of the most common and malignant brain tumors in adulthood with a median survival of only 15 months. This poor prognosis is related to GBM’s ability to extensively infiltrate the surrounding brain parenchyma resulting in diffuse spread of neoplastic cells in the...
Main Authors: | Ekaterina L. Ivanova, Barbara Costa, Tanja Eisemann, Sabrina Lohr, Pavle Boskovic, Viktoria Eichwald, Jasmin Meckler, Manfred Jugold, Veronique Orian-Rousseau, Heike Peterziel, Peter Angel |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.969787/full |
Similar Items
-
Podoplanin Positive Myeloid Cells Promote Glioma Development by Immune Suppression
by: Tanja Eisemann, et al.
Published: (2019-03-01) -
Expression of MMP-14 and CD44 associated with proliferation of retinoblastoma cells
by: Hendrian D. Soebagjo, et al.
Published: (2019-06-01) -
An advanced glioma cell invasion assay based on organotypic brain slice cultures
by: Tanja Eisemann, et al.
Published: (2018-01-01) -
CD44 acts as a signalling platform controlling tumour progression and metastasis
by: Veronique eOrian-Rousseau
Published: (2015-04-01) -
Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?
by: Magdalena Chrabańska, et al.
Published: (2023-02-01)